Christophe Valmaggia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christophe Valmaggia has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Margarita Georgieva Todorova
Department of Ophthalmology, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland
6 shared publications H. Niederberger
4 shared publicationsI. Gottlob
3 shared publicationsI. Haueter
Department of Ophthalmology, Cantonal Hospital St Gallen, St. Gallen, Switzerland (Chairman: Christophe Valmaggia, MD, MBA)
3 shared publications- Cengiz Türksever
Department of Ophthalmology, VISTA Clinic, 4102 Binningen, Switzerland
2 shared publications F. Proudlock
2 shared publications
Latest Publications
- Open Access
- 15 May 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (5) , 1201
Retinal Vessel Flicker Light Responsiveness and Its Relation to Analysis Protocols and Static and Metabolic Data in Healthy Subjects
Background: The aim of this study was to assess the agreement between different analysis protocols for the determination of retinal vessel dilation response to flicker light (FL) and its relation to static and metabolic parameters of retinal vessels in healthy subjects. Methods: In total, 24 right eyes of 24 healthy controls (mean age: 36.04 ± SD 14.4 years) who underwent dynamic and static retinal diameter and oxygen saturation measurements on a Retinal Vessel Analyzer (RVA, Imedos, Jena, Germany) were included. Using repeated video analyses, responses to FL were measured with RVA. These measurements were conducted at three specific retinal locations: within the superotemporal area—within a distance of less than one optic disk (OD) diameter to optic nerve head (ONH) (group 1); greater than one OD diameter to ONH (group 2); and areas near the ONH within the VesselMap region (group 3). For comparability, the static and oxygen saturation parameters were also calculated in the superotemporal peripapillary area using the VesselMap tool of the RVA and were evaluated in relation to the corresponding dynamic area (group 3). Results: In all groups, the vascular FL response of arteries was less pronounced compared to venules (p = 0.0014). Even though FL responses (mean ± SD: FL-A; FL-V) in group 1 were more pronounced (3.36 ± 2.31; 4.42 ± 1.69) compared to those in group 2 (2.97 ± 2.40; 4.08 ± 1.55) and group 3 (2.84 ± 2.29; 4.21 ± 2.03), they did not reach statistically significant values. The mean flicker response of venules (VDil) in all groups showed negative correlations to the corresponding static parameter: central retinal venous equivalent (CRV) (r = −0.0437; p = 0.015). The mean flicker response of arteries (ADil) in all groups showed negative correlations to the corresponding metabolic parameter: arterio-venous oxygen extraction fraction (r = −0.101; p = 0.041). Conclusions: Our study confirms that the flicker light response, despite slight variations in its duration and location, allows for reliable measurements, proving the Retinal Vessel Analyzer to be a valuable diagnostic tool. Furthermore, we were able to highlight the relationship between the dynamic and metabolic components of retinal supply, which enables early diagnosis concerning the development of diseases within this spectrum.
- 15 May 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (5) , 1201
Open AccessRetinal Vessel Flicker Light Responsiveness and Its Relation to Analysis Protocols and Static and Metabolic Data in Healthy Subjects
Background: The aim of this study was to assess the agreement between different analysis protocols for the determination of retinal vessel dilation response to flicker light (FL) and its relation to static and metabolic parameters of retinal vessels in healthy subjects. Methods: In total, 24 right eyes of 24 healthy controls (mean age: 36.04 ± SD 14.4 years) who underwent dynamic and static retinal diameter and oxygen saturation measurements on a Retinal Vessel Analyzer (RVA, Imedos, Jena, Germany) were included. Using repeated video analyses, responses to FL were measured with RVA. These measurements were conducted at three specific retinal locations: within the superotemporal area—within a distance of less than one optic disk (OD) diameter to optic nerve head (ONH) (group 1); greater than one OD diameter to ONH (group 2); and areas near the ONH within the VesselMap region (group 3). For comparability, the static and oxygen saturation parameters were also calculated in the superotemporal peripapillary area using the VesselMap tool of the RVA and were evaluated in relation to the corresponding dynamic area (group 3). Results: In all groups, the vascular FL response of arteries was less pronounced compared to venules (p = 0.0014). Even though FL responses (mean ± SD: FL-A; FL-V) in group 1 were more pronounced (3.36 ± 2.31; 4.42 ± 1.69) compared to those in group 2 (2.97 ± 2.40; 4.08 ± 1.55) and group 3 (2.84 ± 2.29; 4.21 ± 2.03), they did not reach statistically significant values. The mean flicker response of venules (VDil) in all groups showed negative correlations to the corresponding static parameter: central retinal venous equivalent (CRV) (r = −0.0437; p = 0.015). The mean flicker response of arteries (ADil) in all groups showed negative correlations to the corresponding metabolic parameter: arterio-venous oxygen extraction fraction (r = −0.101; p = 0.041). Conclusions: Our study confirms that the flicker light response, despite slight variations in its duration and location, allows for reliable measurements, proving the Retinal Vessel Analyzer to be a valuable diagnostic tool. Furthermore, we were able to highlight the relationship between the dynamic and metabolic components of retinal supply, which enables early diagnosis concerning the development of diseases within this spectrum.
- 25 April 2023
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 240 (04) , 481-485
Postoperative Results in the Treatment of Retinal Detachment with Scleral Buckling Surgery
Background The course after scleral buckling surgery is investigated in patients with rhegmatogenous retinal detachment. Patients and Methods The Ethics Committee of Eastern Switzerland approved the retrospective single-center study (EKOS19/152, Project ID: 2019-02034). The primary endpoint is the anatomical reattachment of the retina 3 months after surgery. Secondary endpoints are visual acuity and the occurrence of intra- and postoperative complications. The patient files of all patients treated for rhegmatogenous retinal detachment with scleral buckling surgery between January 2005 and December 2014 at the Cantonal Hospital of St. Gallen were included. Results In 165 of 184 patients (89.7%), reattachment of the retina 3 months postoperatively was achieved by single scleral buckling surgery. Treatment of rhegmatogenous retinal detachment improved patientsʼ visual acuity by an average of 4.8 ETDRS letters. Intraoperatively, subretinal hemorrhage occurred in one patient. Postoperatively, interfering buckling material was removed in 24 patients (13.1%). A pars plana vitrectomy was performed in six patients (3.2%) due to epiretinal membrane, in two patients (1.1%) due to a macular hole, and in three patients (1.6%) due to disturbing vitreous opacities. Conclusions Scleral buckling surgery is an effective and relatively low complication method for the treatment of selected patients with rhegmatogenous retinal detachment.
- 25 April 2023
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 240 (04) , 481-485
Postoperative Results in the Treatment of Retinal Detachment with Scleral Buckling Surgery
Background The course after scleral buckling surgery is investigated in patients with rhegmatogenous retinal detachment. Patients and Methods The Ethics Committee of Eastern Switzerland approved the retrospective single-center study (EKOS19/152, Project ID: 2019-02034). The primary endpoint is the anatomical reattachment of the retina 3 months after surgery. Secondary endpoints are visual acuity and the occurrence of intra- and postoperative complications. The patient files of all patients treated for rhegmatogenous retinal detachment with scleral buckling surgery between January 2005 and December 2014 at the Cantonal Hospital of St. Gallen were included. Results In 165 of 184 patients (89.7%), reattachment of the retina 3 months postoperatively was achieved by single scleral buckling surgery. Treatment of rhegmatogenous retinal detachment improved patientsʼ visual acuity by an average of 4.8 ETDRS letters. Intraoperatively, subretinal hemorrhage occurred in one patient. Postoperatively, interfering buckling material was removed in 24 patients (13.1%). A pars plana vitrectomy was performed in six patients (3.2%) due to epiretinal membrane, in two patients (1.1%) due to a macular hole, and in three patients (1.6%) due to disturbing vitreous opacities. Conclusions Scleral buckling surgery is an effective and relatively low complication method for the treatment of selected patients with rhegmatogenous retinal detachment.
- 26 April 2022
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 239 (04) , 494-499
“Treat-and-Extend” Regimen for Exudative Age-Related Macular Degeneration: A Two-Year Retrospective Follow-up Study
Background After the introduction of a “treat-and-extend” regimen (T&E) with aflibercept for exudative age-related macular degeneration, naive eyes were compared with eyes pretreated with a “pro re nata” scheme (PRN). Patients and Methods The Ethics Committee of Eastern Switzerland approved the retrospective single-centre study (EKOS20/084, project ID: 2020-01193). The study included 342 eyes of 303 patients newly treated with or switched to T&E between January 2018 and March 2018 at the Eye Clinic of the Cantonal Hospital St. Gallen. The gender distribution of the treated eyes was 63.5% (n = 217) female and 36.5% (n = 125) male. The mean age was 81.6 years (SD = 8.6 years). The collective was divided into three groups: 1) naive, untreated eyes (n = 92), 2) eyes with ≤ 6 previous treatments with PRN (n = 37), 3) eyes with > 6 previous treatments with PRN (n = 213). The following parameters were analysed up to December 2019: the evolution of visual acuity, the number of intravitreal injections, the number of recurrences, the duration of the follow-up, the dropout rate, and the duration of the last treatment interval. Results During the observation period, group 1 showed a statistically significant improvement in visual acuity of + 1.5 ETDRS, while groups 2 and 3 showed a decrease in visual acuity of − 2.9 and − 3.7 ETDRS, respectively. Group 1 had better development of visual acuity than groups 2 and 3 (p = 0.005), while groups 2 and 3 were not significantly different (p = 0.92). The other parameters examined in the three groups did not differ significantly between groups. Conclusions Treatment with aflibercept in T&E shows significantly better visual acuity in naive eyes than in eyes pretreated with PRN. Hintergrund Nach der Einführung eines „Treat-and-Extend“-Schemas (T&E) mit Aflibercept bei exsudativer altersbedingter Makuladegeneration wurden naive Augen mit Augen verglichen, die mit einem „Pro-re-nata“-Schema (PRN) vorbehandelt wurden. Patienten und Methoden Die Ethikkommission der Ostschweiz hat die retrospektive monozentrische Studie bewilligt (EKOS20/084, Projekt-ID: 2020-01193). 342 Augen von 303 Patienten wurden eingeschlossen, die zwischen Januar 2018 und März 2018 in der Augenklinik des Kantonsspitals St. Gallen neu mit T&E behandelt oder darauf umgestellt wurden. Die Geschlechterverteilung der behandelten Augen war 63,5% (n = 217) weiblich und 36,5% (n = 125) männlich. Das mittlere Alter betrug 81,6 Jahre (SD = 8,6 Jahre). Die Einteilung erfolgte in 3 Gruppen: 1. naive, nicht vorbehandelte Augen (n = 92), 2. Augen mit ≤ 6 Vorbehandlungen mit PRN (n = 37), 3. Augen mit > 6 Vorbehandlungen mit PRN (n = 213). Folgende Parameter wurden bis Dezember 2019 analysiert: die Visusentwicklung, die Zahl der intravitrealen Injektionen, die Anzahl der Rezidive, die Follow-up-Dauer, die Abbrecherquote, und die Dauer des letzten Behandlungsintervalls. Ergebnisse Im Beobachtungszeitraum zeigte sich in der Gruppe 1 eine statistisch signifikante Visusverbesserung von + 1,5 ETDRS, während es in der Gruppe 2 und 3 zu einer Visusverschlechterung von − 2,9 bzw. − 3,7 ETDRS kam. Die Gruppe 1 zeigte eine bessere Visusentwicklung als die Gruppen 2 und 3 (p = 0,005), während diese untereinander keinen signifikanten Unterschied zeigten (p = 0,92). Die anderen untersuchten Parameter wichen in den 3 Gruppen nicht signifikant voneinander ab. Schlussfolgerungen Die Behandlung mit Aflibercept in T&E zeigt einen signifikant besseren Visusverlauf bei naiven Augen als bei mit PRN vorbehandelten Augen. Received: 19 September 2021 Accepted: 06 February 2022 Publication Date: 26 April 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 26 April 2022
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 239 (04) , 494-499
“Treat-and-Extend” Regimen for Exudative Age-Related Macular Degeneration: A Two-Year Retrospective Follow-up Study
Background After the introduction of a “treat-and-extend” regimen (T&E) with aflibercept for exudative age-related macular degeneration, naive eyes were compared with eyes pretreated with a “pro re nata” scheme (PRN). Patients and Methods The Ethics Committee of Eastern Switzerland approved the retrospective single-centre study (EKOS20/084, project ID: 2020-01193). The study included 342 eyes of 303 patients newly treated with or switched to T&E between January 2018 and March 2018 at the Eye Clinic of the Cantonal Hospital St. Gallen. The gender distribution of the treated eyes was 63.5% (n = 217) female and 36.5% (n = 125) male. The mean age was 81.6 years (SD = 8.6 years). The collective was divided into three groups: 1) naive, untreated eyes (n = 92), 2) eyes with ≤ 6 previous treatments with PRN (n = 37), 3) eyes with > 6 previous treatments with PRN (n = 213). The following parameters were analysed up to December 2019: the evolution of visual acuity, the number of intravitreal injections, the number of recurrences, the duration of the follow-up, the dropout rate, and the duration of the last treatment interval. Results During the observation period, group 1 showed a statistically significant improvement in visual acuity of + 1.5 ETDRS, while groups 2 and 3 showed a decrease in visual acuity of − 2.9 and − 3.7 ETDRS, respectively. Group 1 had better development of visual acuity than groups 2 and 3 (p = 0.005), while groups 2 and 3 were not significantly different (p = 0.92). The other parameters examined in the three groups did not differ significantly between groups. Conclusions Treatment with aflibercept in T&E shows significantly better visual acuity in naive eyes than in eyes pretreated with PRN. Hintergrund Nach der Einführung eines „Treat-and-Extend“-Schemas (T&E) mit Aflibercept bei exsudativer altersbedingter Makuladegeneration wurden naive Augen mit Augen verglichen, die mit einem „Pro-re-nata“-Schema (PRN) vorbehandelt wurden. Patienten und Methoden Die Ethikkommission der Ostschweiz hat die retrospektive monozentrische Studie bewilligt (EKOS20/084, Projekt-ID: 2020-01193). 342 Augen von 303 Patienten wurden eingeschlossen, die zwischen Januar 2018 und März 2018 in der Augenklinik des Kantonsspitals St. Gallen neu mit T&E behandelt oder darauf umgestellt wurden. Die Geschlechterverteilung der behandelten Augen war 63,5% (n = 217) weiblich und 36,5% (n = 125) männlich. Das mittlere Alter betrug 81,6 Jahre (SD = 8,6 Jahre). Die Einteilung erfolgte in 3 Gruppen: 1. naive, nicht vorbehandelte Augen (n = 92), 2. Augen mit ≤ 6 Vorbehandlungen mit PRN (n = 37), 3. Augen mit > 6 Vorbehandlungen mit PRN (n = 213). Folgende Parameter wurden bis Dezember 2019 analysiert: die Visusentwicklung, die Zahl der intravitrealen Injektionen, die Anzahl der Rezidive, die Follow-up-Dauer, die Abbrecherquote, und die Dauer des letzten Behandlungsintervalls. Ergebnisse Im Beobachtungszeitraum zeigte sich in der Gruppe 1 eine statistisch signifikante Visusverbesserung von + 1,5 ETDRS, während es in der Gruppe 2 und 3 zu einer Visusverschlechterung von − 2,9 bzw. − 3,7 ETDRS kam. Die Gruppe 1 zeigte eine bessere Visusentwicklung als die Gruppen 2 und 3 (p = 0,005), während diese untereinander keinen signifikanten Unterschied zeigten (p = 0,92). Die anderen untersuchten Parameter wichen in den 3 Gruppen nicht signifikant voneinander ab. Schlussfolgerungen Die Behandlung mit Aflibercept in T&E zeigt einen signifikant besseren Visusverlauf bei naiven Augen als bei mit PRN vorbehandelten Augen. Received: 19 September 2021 Accepted: 06 February 2022 Publication Date: 26 April 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 17 February 2022
- Published by Wiley in Acta Ophthalmologica
- Vol. 100 (7) , E1395-E1402
Patients with central serous chorioretinopathy not only have pachychoroidal disorders but also altered retinal metabolic function
Purpose: The aim of our study was to compare metabolic (oxygen saturation; %) and anatomical (diameter; μm) retinal vessel parameters of patients with central serous chorioretinopathy (CSC) to those of controls.Methods: In this prospective cross‐sectional cohort study, 72 eyes of patients with CSC were compared with 21 eyes of healthy controls. Of the 72 patients, 52 had chronic, nonactive CSC (subgroup nCSC) and 20 had active CSC (subgroup aCSC), according to activity on fluorescein angiography. Retinal vessel oximetry (RO) was performed using the Oxymap T1 oximeter. Oxygen saturation in all major peripapillary retinal arterioles (A‐SO2) and venules (V‐SO2) was measured, and their difference (A‐V SO2) was calculated. In addition, we evaluated the corresponding diameter in retinal arterioles (D‐A) and venules (D‐V). For statistical evaluation, ANOVA‐based linear mixed‐effects models were calculated (SPSS®; p < 0.05).Results: Central serous chorioretinopathy (CSC) patients had significantly higher A‐SO2 and V‐SO2 compared to that of controls (p = 0.031 and p = 0.018 respectively). Especially, the subgroup of aCSC patients showed significantly higher A‐SO2 and V‐SO2 values (p = 0.027 and p = 0.034, respectively). In addition, superotemporal and superonasal quadrant location showed significant interactions with A‐SO2 and V‐SO2 (p ≤ 0.03). Diameter in retinal arterioles (D‐A), an venules (D‐V) and A‐V SO2 findings showed no significant differences (p > 0.096).Conclusion: These data indicate that patients with CSC have altered metabolic function. The presence of disease activity showed the greatest influence on RO measurement, both compared to controls and to those with inactive chronic CSC disease.
- 17 February 2022
- Published by Wiley in Acta Ophthalmologica
- Vol. 100 (7) , E1395-E1402
Patients with central serous chorioretinopathy not only have pachychoroidal disorders but also altered retinal metabolic function
Purpose: The aim of our study was to compare metabolic (oxygen saturation; %) and anatomical (diameter; μm) retinal vessel parameters of patients with central serous chorioretinopathy (CSC) to those of controls.Methods: In this prospective cross‐sectional cohort study, 72 eyes of patients with CSC were compared with 21 eyes of healthy controls. Of the 72 patients, 52 had chronic, nonactive CSC (subgroup nCSC) and 20 had active CSC (subgroup aCSC), according to activity on fluorescein angiography. Retinal vessel oximetry (RO) was performed using the Oxymap T1 oximeter. Oxygen saturation in all major peripapillary retinal arterioles (A‐SO2) and venules (V‐SO2) was measured, and their difference (A‐V SO2) was calculated. In addition, we evaluated the corresponding diameter in retinal arterioles (D‐A) and venules (D‐V). For statistical evaluation, ANOVA‐based linear mixed‐effects models were calculated (SPSS®; p < 0.05).Results: Central serous chorioretinopathy (CSC) patients had significantly higher A‐SO2 and V‐SO2 compared to that of controls (p = 0.031 and p = 0.018 respectively). Especially, the subgroup of aCSC patients showed significantly higher A‐SO2 and V‐SO2 values (p = 0.027 and p = 0.034, respectively). In addition, superotemporal and superonasal quadrant location showed significant interactions with A‐SO2 and V‐SO2 (p ≤ 0.03). Diameter in retinal arterioles (D‐A), an venules (D‐V) and A‐V SO2 findings showed no significant differences (p > 0.096).Conclusion: These data indicate that patients with CSC have altered metabolic function. The presence of disease activity showed the greatest influence on RO measurement, both compared to controls and to those with inactive chronic CSC disease.
- 29 September 2021
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 238 (12) , 1299-1304
Thermal Laser Monotherapy for Extrafoveal Polypoidal Choroidal Vasculopathy
Introduction Polypoidal choroidal vasculopathy (PCV) is a vascular disease of the choroid. Diagnosis is mainly based on polypoidal aneurysm-like lesions seen in indocyanine green (ICG) angiography. Various therapeutic options have been proposed. Methods Outcomes of 10 cases with extrafoveal PCV and consecutive macular edema treated with thermal laser are reported. Diagnosis of PCV was confirmed by ICG angiography. Results Upon successful occlusion of the polyps in 10 eyes after thermal laser treatment demonstrated in ICG angiography, a regression of central foveal edema was seen in optical coherence tomography and color fundus photography. Visual acuity improved from logMAR 0.8 to logMAR 0.3. Follow-up ranged from 4 months to 15 years, with a median of 1 year. Two eyes had a recurrence of exudative maculopathy 5 and 7 years after laser treatment, respectively. Conclusion A careful differentiation between various subforms of exudative maculopathy using fluorescein and ICG angiography can identify certain selected patients with extrafoveal PCV, for whom thermal laser monotherapy can be a therapeutic option.
- 29 September 2021
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 238 (12) , 1299-1304
Thermal Laser Monotherapy for Extrafoveal Polypoidal Choroidal Vasculopathy
Introduction Polypoidal choroidal vasculopathy (PCV) is a vascular disease of the choroid. Diagnosis is mainly based on polypoidal aneurysm-like lesions seen in indocyanine green (ICG) angiography. Various therapeutic options have been proposed. Methods Outcomes of 10 cases with extrafoveal PCV and consecutive macular edema treated with thermal laser are reported. Diagnosis of PCV was confirmed by ICG angiography. Results Upon successful occlusion of the polyps in 10 eyes after thermal laser treatment demonstrated in ICG angiography, a regression of central foveal edema was seen in optical coherence tomography and color fundus photography. Visual acuity improved from logMAR 0.8 to logMAR 0.3. Follow-up ranged from 4 months to 15 years, with a median of 1 year. Two eyes had a recurrence of exudative maculopathy 5 and 7 years after laser treatment, respectively. Conclusion A careful differentiation between various subforms of exudative maculopathy using fluorescein and ICG angiography can identify certain selected patients with extrafoveal PCV, for whom thermal laser monotherapy can be a therapeutic option.
- Open Access
- 10 April 2021
- Published by Springer Nature in BMC Ophthalmology
- Vol. 21 (1) , 1-6
Comparative study of combined vitrectomy with phacoemulsification versus vitrectomy alone for primary full-thickness macular hole repair
Background: To assess the effectiveness and safety of 23-gauge pars plana vitrectomy combined with phacoemulsification versus vitrectomy alone in patients over 50 years with primary full-thickness macular holes (FTMH). Methods: We retrospectively reviewed the medical records related to 406 consecutive vitrectomies performed for primary FTMH. Phacovitrectomy was performed in 294 phakic eyes whereas vitrectomy alone in 112 pseudophakic eyes. The cases were divided into three groups according to the stage of the FTMH: stage 2 (n = 93), stage 3 (n = 270), or stage 4 (n = 43). The primary outcome measure was the closure of the FTMH. The secondary outcome measures were the evolution of visual acuity as well as intraoperative and postoperative complications. Results: Neither the primary nor the secondary outcomes differed between phacovitrectomy and vitrectomy alone for all three stages. The FTMH were closed in 375 eyes (92.4 %) after a first operation. The closure rate was higher for stage 2 (96.8 %) than for stages 3 (91.1 %) or 4 (90.75 %), but not significantly (P = 0.189). The mean visual acuity increased significantly from preoperatively LogMAR 0.68 (± SD 0.2) to LogMAR 0.43 (± SD 0.24) at the end of the follow-up (p < 0.001). Conclusions: Combined 23-gauge pars plana vitrectomy with phacoemulsification for primary FTMH repair in patients over 50 years is as efficient and safe when compared with vitrectomy only. Trial registration: The study was approved on 30th April 2020 by the local ethics committee (Ethikkommission Ostschweiz, EKOS 20/074; BASEC Nr. 2020-01033).
- 10 April 2021
- Published by Springer Nature in BMC Ophthalmology
- Vol. 21 (1) , 1-6
Open AccessComparative study of combined vitrectomy with phacoemulsification versus vitrectomy alone for primary full-thickness macular hole repair
Background: To assess the effectiveness and safety of 23-gauge pars plana vitrectomy combined with phacoemulsification versus vitrectomy alone in patients over 50 years with primary full-thickness macular holes (FTMH). Methods: We retrospectively reviewed the medical records related to 406 consecutive vitrectomies performed for primary FTMH. Phacovitrectomy was performed in 294 phakic eyes whereas vitrectomy alone in 112 pseudophakic eyes. The cases were divided into three groups according to the stage of the FTMH: stage 2 (n = 93), stage 3 (n = 270), or stage 4 (n = 43). The primary outcome measure was the closure of the FTMH. The secondary outcome measures were the evolution of visual acuity as well as intraoperative and postoperative complications. Results: Neither the primary nor the secondary outcomes differed between phacovitrectomy and vitrectomy alone for all three stages. The FTMH were closed in 375 eyes (92.4 %) after a first operation. The closure rate was higher for stage 2 (96.8 %) than for stages 3 (91.1 %) or 4 (90.75 %), but not significantly (P = 0.189). The mean visual acuity increased significantly from preoperatively LogMAR 0.68 (± SD 0.2) to LogMAR 0.43 (± SD 0.24) at the end of the follow-up (p < 0.001). Conclusions: Combined 23-gauge pars plana vitrectomy with phacoemulsification for primary FTMH repair in patients over 50 years is as efficient and safe when compared with vitrectomy only. Trial registration: The study was approved on 30th April 2020 by the local ethics committee (Ethikkommission Ostschweiz, EKOS 20/074; BASEC Nr. 2020-01033).
- 22 February 2021
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 238 (04) , 378-379
Familial Congenital Megalocornea and Spherophakia: A Case Series
Megalocornea is a rare, nonprogressive, congenital defect characterized by enlargement of the corneal diameter greater than 13 mm at birth. The involvement is typically bilateral but can be asymmetric. The anterior segment is widened at the expense of the vitreous length and the intraocular pressure is normal. The defect falls into the category of anterior segment dysgenesis and may be associated with several other conditions, including arcus lipoides, mosaic corneal dystrophy, or iris atrophy and transillumination. The disease is generally asymptomatic in childhood, although the astigmatism due to the large cornea can lead to blurred vision. Nevertheless, patients with megalocornea are prone to zonular deficiencies and subluxation of the lens. Adults may experience premature nuclear sclerotic cataract formation, typically between the ages of 30 and 50 [1], [2]. Megalocornea was first described in 1869, but the genetic basis of this disease has only been elucidated in the past decade. In 90% of the cases, males are affected, since the observed inheritance pattern is predominantly x-linked [3]. In early childhood its differentiation from glaucoma-associated buphthalmos can be challenging [4], [5]. In some patients, megalocornea may also be associated with different congenital syndromes such as Marfan syndrome, or Neuhauser syndrome (megalocornea-mental retardation syndrome) [2], [6]. Received: 01 July 2020 Accepted: 06 January 2021 Publication Date: 22 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 22 February 2021
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
- Vol. 238 (04) , 378-379
Familial Congenital Megalocornea and Spherophakia: A Case Series
Megalocornea is a rare, nonprogressive, congenital defect characterized by enlargement of the corneal diameter greater than 13 mm at birth. The involvement is typically bilateral but can be asymmetric. The anterior segment is widened at the expense of the vitreous length and the intraocular pressure is normal. The defect falls into the category of anterior segment dysgenesis and may be associated with several other conditions, including arcus lipoides, mosaic corneal dystrophy, or iris atrophy and transillumination. The disease is generally asymptomatic in childhood, although the astigmatism due to the large cornea can lead to blurred vision. Nevertheless, patients with megalocornea are prone to zonular deficiencies and subluxation of the lens. Adults may experience premature nuclear sclerotic cataract formation, typically between the ages of 30 and 50 [1], [2]. Megalocornea was first described in 1869, but the genetic basis of this disease has only been elucidated in the past decade. In 90% of the cases, males are affected, since the observed inheritance pattern is predominantly x-linked [3]. In early childhood its differentiation from glaucoma-associated buphthalmos can be challenging [4], [5]. In some patients, megalocornea may also be associated with different congenital syndromes such as Marfan syndrome, or Neuhauser syndrome (megalocornea-mental retardation syndrome) [2], [6]. Received: 01 July 2020 Accepted: 06 January 2021 Publication Date: 22 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
Retinal Oxygenation in Inherited Diseases of the Retina
(1) Background: The aim of our study was to investigate the relationship between retinal metabolic alterations (retinal vessel oximetry, RO) and structural findings (retinal vessel diameter, central retinal thickness and retinal nerve fiber layer thickness, RNFL) in patients with inherited retinal diseases (IRDs). (2) Methods: A total of 181 eyes of 92 subjects were examined: 121 eyes of 62 patients with IRDs were compared to 60 eyes of 30 healthy age-matched controls. The retinal vessel oximetry was performed with the oxygen saturation measurement tool of the Retinal Vessel Analyser (RVA; IMEDOS Systems UG, Jena, Germany). The oxygen saturation in all four major peripapillary retinal arterioles (A-SO2; %) and venules (V-SO2; %) were measured and their difference (A-V SO2; %) was calculated. Additionally, retinal vessel diameters of the corresponding arterioles (D-A; µm) and venules (D-V; µm) were determined. The peripapillary central retinal thickness and the RNFL thickness were measured using spectral domain optical coherence tomography (SD-OCT) (Carl Zeiss Meditec, Dublin, CA, USA). Moreover, we calculated the mean central retinal oxygen exposure (cO2-E; %/µm) and the mean peripapillary oxygen exposure (pO2-E; %/µm) per micron of central retinal thickness and nerve fiber layer thickness by dividing the mean central retinal thickness (CRT) and the RNFL thickness with the mean A-V SO2. (3) Results: Rod-cone dystrophy patients had the highest V-SO2 and A-SO2, the lowest A-V SO2, the narrowest D-A and D-V and the thickest RNFL, when compared not only to controls (p ≤ 0.040), but also to patients with other IRDs. Furthermore, in rod-cone dystrophies the cO2-E and the pO2-E were higher in comparison to controls and to patients with other IRDs (p ≤ 0.005). Cone-rod dystrophy patients had the lowest cO2-E compared to controls and patients with other IRDs (p ≤ 0.035). Evaluated in central zones, the cO2-E was significantly different when comparing cone-rod dystrophy (CRD) against rod-cone dystrophy (RCD) patients in all zones (p < 0.001), whereas compared with controls and patients with inherited macular dystrophy this was observed only in zones 1 and 2 (p ≤ 0.018). The oxygen exposure was also the highest in the RCD group for both the nasal and the temporal peripapillary area, among all the evaluated groups (p ≤ 0.025). (4) Conclusions: The presented metabolic-structural approach enhances our understanding of inherited photoreceptor degenerations. Clearly demonstrated through the O2-E comparisons, the central and the peripapillary retina in rod-cone dystrophy eyes consume less oxygen than the control-eyes and eyes with other IRDs. Rod-cone dystrophy eyes seem to be proportionally more exposed to oxygen, the later presumably leading to more pronounced oxidative damage-related remodeling.
Open AccessRetinal Oxygenation in Inherited Diseases of the Retina
(1) Background: The aim of our study was to investigate the relationship between retinal metabolic alterations (retinal vessel oximetry, RO) and structural findings (retinal vessel diameter, central retinal thickness and retinal nerve fiber layer thickness, RNFL) in patients with inherited retinal diseases (IRDs). (2) Methods: A total of 181 eyes of 92 subjects were examined: 121 eyes of 62 patients with IRDs were compared to 60 eyes of 30 healthy age-matched controls. The retinal vessel oximetry was performed with the oxygen saturation measurement tool of the Retinal Vessel Analyser (RVA; IMEDOS Systems UG, Jena, Germany). The oxygen saturation in all four major peripapillary retinal arterioles (A-SO2; %) and venules (V-SO2; %) were measured and their difference (A-V SO2; %) was calculated. Additionally, retinal vessel diameters of the corresponding arterioles (D-A; µm) and venules (D-V; µm) were determined. The peripapillary central retinal thickness and the RNFL thickness were measured using spectral domain optical coherence tomography (SD-OCT) (Carl Zeiss Meditec, Dublin, CA, USA). Moreover, we calculated the mean central retinal oxygen exposure (cO2-E; %/µm) and the mean peripapillary oxygen exposure (pO2-E; %/µm) per micron of central retinal thickness and nerve fiber layer thickness by dividing the mean central retinal thickness (CRT) and the RNFL thickness with the mean A-V SO2. (3) Results: Rod-cone dystrophy patients had the highest V-SO2 and A-SO2, the lowest A-V SO2, the narrowest D-A and D-V and the thickest RNFL, when compared not only to controls (p ≤ 0.040), but also to patients with other IRDs. Furthermore, in rod-cone dystrophies the cO2-E and the pO2-E were higher in comparison to controls and to patients with other IRDs (p ≤ 0.005). Cone-rod dystrophy patients had the lowest cO2-E compared to controls and patients with other IRDs (p ≤ 0.035). Evaluated in central zones, the cO2-E was significantly different when comparing cone-rod dystrophy (CRD) against rod-cone dystrophy (RCD) patients in all zones (p < 0.001), whereas compared with controls and patients with inherited macular dystrophy this was observed only in zones 1 and 2 (p ≤ 0.018). The oxygen exposure was also the highest in the RCD group for both the nasal and the temporal peripapillary area, among all the evaluated groups (p ≤ 0.025). (4) Conclusions: The presented metabolic-structural approach enhances our understanding of inherited photoreceptor degenerations. Clearly demonstrated through the O2-E comparisons, the central and the peripapillary retina in rod-cone dystrophy eyes consume less oxygen than the control-eyes and eyes with other IRDs. Rod-cone dystrophy eyes seem to be proportionally more exposed to oxygen, the later presumably leading to more pronounced oxidative damage-related remodeling.
- Open Access
- 17 January 2021
- Published by Wiley in Acta Ophthalmologica
- Vol. 99 (S265)
How the tophic problems and the rubbing eye behavior may aggravate the presence of keratoconus in trisomy 21
Purpose: Down syndrome is a congenital anomaly caused by non‐dislocation of chromosome 21. Ocular features in trisomy 21 patients, such as changes in corneal collagen composition as well as thinning predisposing to keratoconus are well appreciated. We present a case of unilateral acute corneal hydrops in a young adult with trisomy 21, and the management to prevent corneal perforation yielding a successful visual outcome.Method: A 20‐year‐old man presented in our emergency department due to sudden visual loss and severe left ocular pain. Visual acuity was 20/200 in the right eye, and finger counting in the left. Anterior segment examination revealed pigmented endothelial cells and endothelial cell count reduced to 2583 CD/mm2 in the right eye, as well as a very large central corneal leukoma and corneal ectasia in the right eye. Corneal topography confirmed the presence of an acute corneal hydrops in the left eye as well as milder keratoconus in the right.Results: Apart from topical steroid drops, oral acetazolamide and timolol drops were used to reduce the intraocular pressure on a decompensated cornea with reduced endothelial cell count. Penetrating keratoplasty was eventually necessary. Due to intolerance and insufficient patient ability to use form‐stable contact lenses, a cross‐linking procedure was performed to stabilize the right eye. Both surgeries lead to best‐corrected acuity of 20/50 OU without a need for additional contact lens correction. Surface issues related to trisomy 21 were addressed using topical lubricants.Conclusion: In the presented case, preexisting keratoconus, worsened by frequent eye rubbing of abnormal collagen composition corneas, permits transmission of mechanical forces to thinner exposed tissue, leading to acute hydrops. The extensive corneal tissue damage that occurred with stromal scarring left necessitates keratoplasty to successfully restore vision. This case highlights the need for preventive ophthalmic examinations in patients of trisomy 21 to rule out the presence of keratoconus. The timely application of lubricants, as well as anti‐histamines and mast cell stabilizers could reduce the eye rubbing behavior that aggravates corneal anomalies in such mentally handicapped individuals. This may reduce progression and eventual need for surgical interventions.
- 17 January 2021
- Published by Wiley in Acta Ophthalmologica
- Vol. 99 (S265)
Open AccessHow the tophic problems and the rubbing eye behavior may aggravate the presence of keratoconus in trisomy 21
Purpose: Down syndrome is a congenital anomaly caused by non‐dislocation of chromosome 21. Ocular features in trisomy 21 patients, such as changes in corneal collagen composition as well as thinning predisposing to keratoconus are well appreciated. We present a case of unilateral acute corneal hydrops in a young adult with trisomy 21, and the management to prevent corneal perforation yielding a successful visual outcome.Method: A 20‐year‐old man presented in our emergency department due to sudden visual loss and severe left ocular pain. Visual acuity was 20/200 in the right eye, and finger counting in the left. Anterior segment examination revealed pigmented endothelial cells and endothelial cell count reduced to 2583 CD/mm2 in the right eye, as well as a very large central corneal leukoma and corneal ectasia in the right eye. Corneal topography confirmed the presence of an acute corneal hydrops in the left eye as well as milder keratoconus in the right.Results: Apart from topical steroid drops, oral acetazolamide and timolol drops were used to reduce the intraocular pressure on a decompensated cornea with reduced endothelial cell count. Penetrating keratoplasty was eventually necessary. Due to intolerance and insufficient patient ability to use form‐stable contact lenses, a cross‐linking procedure was performed to stabilize the right eye. Both surgeries lead to best‐corrected acuity of 20/50 OU without a need for additional contact lens correction. Surface issues related to trisomy 21 were addressed using topical lubricants.Conclusion: In the presented case, preexisting keratoconus, worsened by frequent eye rubbing of abnormal collagen composition corneas, permits transmission of mechanical forces to thinner exposed tissue, leading to acute hydrops. The extensive corneal tissue damage that occurred with stromal scarring left necessitates keratoplasty to successfully restore vision. This case highlights the need for preventive ophthalmic examinations in patients of trisomy 21 to rule out the presence of keratoconus. The timely application of lubricants, as well as anti‐histamines and mast cell stabilizers could reduce the eye rubbing behavior that aggravates corneal anomalies in such mentally handicapped individuals. This may reduce progression and eventual need for surgical interventions.
- Open Access
- 14 December 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (12) , 4037
Predictive Risk Factors for Retinal Redetachment Following Uncomplicated Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment
Purpose: To investigate clinical and surgical factors influencing the outcome after primary rhegmatogenous retinal detachment surgery. Methods: A retrospective, single-centre, case-control study of 1017 eyes of 1017 consecutive patients with primary rhegmatogenous retinal detachment (RRD) who underwent pars plana vitrectomy (PPV), were included in the study. Analysed surgical factors were: combined procedure with phacoemulsification, type of retinopexy (cryocoagulation, endolaser, combined), type of tamponade (gas, silicone oil), and anatomical factors: primary proliferative vitreoretinopathy (PVR) and macular detachment at the time of surgery. Results: Overall retinal re-detachment rate was 10.1%. The main reason for re-detachment was an insufficient retinopexy in 53.6%, followed by PVR (37.3%), and retinal detachment occurred at a different location caused by another break in 9.1%. No significant difference in the rate of re-detachment was found if a phacoemulsification with simultaneous IOL implantation was performed (p = 0.641). No significant difference between the various retinopexy techniques was found (p = 0.309). Risk factors re-detachment were primary PVR (p = 0.0003), silicone oil as initial tamponade (p = 0.0001) as well as macula off detachments (p = 0.034). Conclusions: The present study showed no significant difference between the types of retinopexy and if additional phacoemulsification was performed or not. Factors associated with a higher risk for re-detachment were detached macula at surgery, primary PVR and primary oil-filling.
- 14 December 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (12) , 4037
Open AccessPredictive Risk Factors for Retinal Redetachment Following Uncomplicated Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment
Purpose: To investigate clinical and surgical factors influencing the outcome after primary rhegmatogenous retinal detachment surgery. Methods: A retrospective, single-centre, case-control study of 1017 eyes of 1017 consecutive patients with primary rhegmatogenous retinal detachment (RRD) who underwent pars plana vitrectomy (PPV), were included in the study. Analysed surgical factors were: combined procedure with phacoemulsification, type of retinopexy (cryocoagulation, endolaser, combined), type of tamponade (gas, silicone oil), and anatomical factors: primary proliferative vitreoretinopathy (PVR) and macular detachment at the time of surgery. Results: Overall retinal re-detachment rate was 10.1%. The main reason for re-detachment was an insufficient retinopexy in 53.6%, followed by PVR (37.3%), and retinal detachment occurred at a different location caused by another break in 9.1%. No significant difference in the rate of re-detachment was found if a phacoemulsification with simultaneous IOL implantation was performed (p = 0.641). No significant difference between the various retinopexy techniques was found (p = 0.309). Risk factors re-detachment were primary PVR (p = 0.0003), silicone oil as initial tamponade (p = 0.0001) as well as macula off detachments (p = 0.034). Conclusions: The present study showed no significant difference between the types of retinopexy and if additional phacoemulsification was performed or not. Factors associated with a higher risk for re-detachment were detached macula at surgery, primary PVR and primary oil-filling.